Freedom Investment Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,963
| Closed | -$208K | – | 798 |
|
|
2024
Q1 | $208K | Buy |
+2,963
| New | +$208K | 0.02% | 740 |
|
|
2023
Q1 | – | Sell |
-6,057
| Closed | -$278K | – | 713 |
|
|
2022
Q4 | $278K | Sell |
6,057
-350
| -5% | -$16K | 0.03% | 595 |
|
|
2022
Q3 | $310K | Sell |
6,407
-249
| -4% | -$12.1K | 0.04% | 560 |
|
|
2022
Q2 | $262K | Buy |
+6,656
| New | +$262K | 0.03% | 615 |
|
|
2018
Q2 | – | Sell |
-138,296
| Closed | -$996K | – | 986 |
|
|
2018
Q1 | $996K | Buy |
138,296
+2,526
| +2% | +$18.2K | 0.05% | 371 |
|
|
2017
Q4 | $1.11M | Buy |
135,770
+3,949
| +3% | +$32.2K | 0.06% | 331 |
|
|
2017
Q3 | $1.91M | Sell |
131,821
-6,315
| -5% | -$91.5K | 0.1% | 148 |
|
|
2017
Q2 | $1.67M | Buy |
138,136
+830
| +0.6% | +$10K | 0.1% | 164 |
|
|
2017
Q1 | $1.76M | Sell |
137,306
-18,396
| -12% | -$236K | 0.1% | 142 |
|
|
2016
Q4 | $1.89M | Sell |
155,702
-38,653
| -20% | -$470K | 0.12% | 107 |
|
|
2016
Q3 | $1.78M | Sell |
194,355
-5,423
| -3% | -$49.8K | 0.11% | 115 |
|
|
2016
Q2 | $1.9M | Buy |
199,778
+9,514
| +5% | +$90.3K | 0.13% | 89 |
|
|
2016
Q1 | $1.34M | Buy |
190,264
+63,809
| +50% | +$450K | 0.1% | 150 |
|
|
2015
Q4 | $1.32M | Buy |
126,455
+110,508
| +693% | +$1.16M | 0.1% | 159 |
|
|
2015
Q3 | $1.54M | Sell |
15,947
-66,532
| -81% | -$6.42M | 0.16% | 94 |
|
|
2015
Q2 | $554K | Buy |
82,479
+23,854
| +41% | +$160K | 0.06% | 309 |
|
|
2015
Q1 | $397K | Buy |
58,625
+28,983
| +98% | +$196K | 0.04% | 386 |
|
|
2014
Q4 | $237K | Buy |
+29,642
| New | +$237K | 0.03% | 503 |
|